Study of NY-ESO-1 ISCOMATRIX® in Patients With High-risk, Resected Melanoma
Clinical trial NCT00199901 · COMPLETED
Trial details
- NCT number
- NCT00199901
- Sponsor
- Ludwig Institute for Cancer Research
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-09-01
- Primary completion
- 2008-12-01
- Enrollment
- 111
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.